1. Home
  2. SHEN vs JANX Comparison

SHEN vs JANX Comparison

Compare SHEN & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$14.00

Market Cap

803.5M

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$13.80

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
JANX
Founded
1902
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
803.5M
790.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
SHEN
JANX
Price
$14.00
$13.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$26.00
$53.60
AVG Volume (30 Days)
229.2K
739.0K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$357,854,000.00
$10,000,000.00
Revenue This Year
$6.58
N/A
Revenue Next Year
N/A
$209.90
P/E Ratio
N/A
N/A
Revenue Growth
9.08
N/A
52 Week Low
$9.67
$12.12
52 Week High
$15.92
$35.34

Technical Indicators

Market Signals
Indicator
SHEN
JANX
Relative Strength Index (RSI) 50.57 49.46
Support Level $13.97 $13.80
Resistance Level $15.86 $14.46
Average True Range (ATR) 0.62 0.57
MACD -0.15 0.04
Stochastic Oscillator 26.36 57.05

Price Performance

Historical Comparison
SHEN
JANX

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: